Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2009
02/12/2009WO2007011696A8 Compositions and methods for coupling a plurality of compounds to a scaffold
02/12/2009US20090044299 Artichoke hybrid named 'PS-H2015'
02/12/2009US20090043107 Process for Synthesizing Compounds Useful for Treating Hepatitis C
02/12/2009US20090042965 Inhibitors for steroid response elements and related methods
02/12/2009US20090042962 Therapeutic Agent for Keratoconjunctival Disorder
02/12/2009US20090042948 Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
02/12/2009US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/12/2009US20090042904 Substituted Phenly-Piperazine Compounds, Their Preparation And Use In Medicaments
02/12/2009US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics
02/12/2009US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists
02/12/2009US20090042883 Antitumor agent
02/12/2009US20090042880 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
02/12/2009US20090042879 Phthalazinone derivatives and pharmaceutical compositions comprising the same
02/12/2009US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control
02/12/2009US20090042864 Pyrazole compounds
02/12/2009US20090042862 Novel compounds
02/12/2009US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists
02/12/2009US20090042806 Transglutaminase inhibitors and methods of use thereof
02/12/2009US20090041716 Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
02/12/2009US20090041664 5-Pyrrolidinylsulfonyl Isatin Derivatives
02/12/2009US20090039771 Organic electroluminescent element material, organic electroluminescent element, display device and lighting device
02/12/2009CA2695729A1 Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
02/12/2009CA2695711A1 Process for synthesizing compounds useful for treating hepatitis c
02/12/2009CA2695437A1 Aminopyrazole amide derivative
02/11/2009EP2022785A1 Alkynylpyrimidines as Tie2 kinase inhibitors
02/11/2009EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase
02/11/2009EP2021330A2 Benzimidazole modulators of vr1
02/11/2009EP2021329A1 Inhibitors of c-fms kinase
02/11/2009EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
02/11/2009EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/11/2009CN101365696A Compounds and compositions as modulators of steroid hormone nuclear receptors
02/11/2009CN101365695A Quinazoline derivatives as anticancer agents
02/11/2009CN101365694A Heterocycle-substituted 3-alkyl azetidine derivatives
02/11/2009CN101365687A Piperazine compounds with a herbicidal action
02/11/2009CN101365685A 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the TRPV1 receptor
02/11/2009CN101365679A Methods and compounds for preparing cc-1065 analogs
02/11/2009CN101365678A Modulators of the h3 receptor useful for the treatment of disorders related thereto
02/11/2009CN101365676A Azetidines as mek inhibitors for the treatment of proliferative diseases
02/11/2009CN101362773A Heterocyclic boronic acid compounds
02/11/2009CN101362751A Tandospirone citrate, preparation method thereof, formulations and quality control method
02/11/2009CN101362750A Losartan preparation method
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/10/2009US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory
02/10/2009US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
02/10/2009US7488744 Indole-type derivatives as inhibitors of p38 kinase
02/10/2009US7488734 Anticancer agents; hormone replacement therapy; contraceptives
02/10/2009US7488731 Arylpiperazinyl compounds
02/10/2009US7488725 To treat diabetes, especially type II diabetes including complications of diabetes; synergistic
02/10/2009US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent
02/10/2009CA2451229C Indole derivatives
02/10/2009CA2208671C Substituted imides as tnf inhibitors
02/10/2009CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
02/10/2009CA2186511C Pyrimidinyl derivatives as interleukin inhibitors
02/05/2009WO2009017394A1 Substituted cc-1065 analogs and their conjugates
02/05/2009WO2009016498A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
02/05/2009WO2009016460A2 Pyrazole compounds and their use as raf inhibitors
02/05/2009WO2009016227A2 Novel compounds
02/05/2009WO2009016222A1 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives
02/05/2009WO2008137134A3 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
02/05/2009WO2008125691A3 Ethers of naphtalene carboxylic acid amides as cancer cure
02/05/2009WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
02/05/2009WO2007003521A3 Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
02/05/2009US20090036687 Multinuclear complex and condensation product thereof
02/05/2009US20090036676 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
02/05/2009US20090036505 Angiotensin II receptor antagonists such as 2-butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)1,1'-biphenyl-methyl]imidazole-5-carboxylic acid, pivaloyloxymethyl ester, used as hypotensive agents
02/05/2009US20090036493 Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex
02/05/2009US20090036485 Quinoline derivatives
02/05/2009US20090036476 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
02/05/2009US20090036474 Quinazoline derivatives for use against cancer
02/05/2009US20090036466 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
02/05/2009US20090036463 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
02/05/2009US20090036460 Crystalline pyridazine compound
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036455 Arylpiperazine derivative and use thereof as 5-ht1a receptor ligands
02/05/2009US20090036452 Taar1 ligands
02/05/2009US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors
02/05/2009US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof
02/05/2009US20090036447 Compounds, Compositions and Methods
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036438 Five-membered heterocycles useful as serine protease inhibitors
02/05/2009US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/2009US20090036421 Pyrrole Derivative or Salt Thereof
02/05/2009US20090035810 Modified carbocyanine dyes and their conjugates
02/05/2009US20090035809 Modified Carbocyanine Dyes and Their Conjugates
02/05/2009US20090035324 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections
02/05/2009US20090032106 N-type conjugated materials based on 2-vinyl-4,5-dicyanoimidazoles and their use in organic photovoltaics
02/05/2009CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
02/05/2009CA2695297A1 Substituted cc-1065 analogs and their conjugates
02/05/2009CA2695114A1 Pyrazole compounds and their use as raf inhibitors
02/04/2009EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity
02/04/2009EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
02/04/2009EP2019674A2 Histone deacetylase and tubulin deacetylase inhibitors
02/04/2009CN101360740A Aminopyrimidines useful as kinase inhibitors
02/04/2009CN101360739A Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes
02/04/2009CN101360707A Thrombopoietin activity modulating compounds and methods
02/04/2009CN100457731C Benzamide modulators of metabotropic glutamate receptors
02/04/2009CN100457730C Indoles having anti-diabetic activity
02/04/2009CN100457728C Tyrosine kinase inhibitors
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/03/2009US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives